EverFlex Self-expanding Peripheral Stent System
Medtronic Vascular, Inc. · Decision date Jul 10, 2026
What did the FDA decide?
FDA records P110023/S068 as a supplement to PMA P110023, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 10, 2026.
FDA approval order statement
Changes to the fixture used with the Branson Ultrasonic Welder and manifold inspection associated with this process.
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Jul 10, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P110023/S068
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic Vascular, Inc.
- Product code
- NIP
- Decision code
- OK30
- Decision date
- Jul 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.
- Applicant
- Medtronic Vascular, Inc.
- Product code
- NIP
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P110023. Subsequent supplements may change the device or its indications.
FDA decision timeline
P110023 · Original PMA
EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)
P110023/S060 · Related supplement
EverFlex Self-Expanding Peripheral Stent System; EverFlex Self-Expanding Peripheral Stent with Entrust Delivery Syste
P110023/S056 · Related supplement
EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)
P110023/S062 · Related supplement
EverFlex Self-expanding Peripheral Stent System
P110023/S061 · Related supplement
EverFlex self-expanding Peripheral Stent System (EverFlex)
P110023/S063 · Related supplement
EverFlex Self-Expanding Peripheral Stent System; EverFlex Self-Expanding Peripheral Stent with Entrust Delivery Syste
P110023/S065 · Related supplement
EverFlex Self-Expanding Peripheral Stent System; EverFlex Self-Expanding Peripheral Stent with Entrust Delivery Syste
P110023/S064 · Related supplement
EverFlex Self-Expanding Peripheral Stent System; EverFlex Self-Expanding Peripheral Stent with Entrust Delivery Syste
P110023/S066 · Related supplement
EverFlex Self-Expanding Peripheral Stent System; EverFlex Self-Expanding Peripheral Stent with Entrust Delivery Syste
P110023/S067 · Related supplement
Everflex Self-Expanding Peripheral Stent System, EverFlex Self-Expanding Peripheral Stent with Entrust Delivery Syste
P110023/S068 received
Application receipt date recorded by FDA.
P110023/S068 · FDA decision
30-Day Notice
P110023/S069 · Related supplement
EverFlex Self-Expanding Peripheral Stent System; EverFlex Self-Expanding Peripheral Stent with Entrust Delivery Syste
P110023/S070 · Related supplement
EVERFLEX SELF-EXPANDING PERIPHERAL STENT SYSTEM (EVERFLEX)
Timeline entries are records held by MedtechLedger for P110023. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P110023
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Vascular, Inc. | PMA approval | Mar 7, 2012 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Jul 25, 2025 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Aug 5, 2025 | FDA | |
EverFlex Self-expanding Peripheral Stent SystemP110023/S062 | Medtronic Vascular, Inc. | PMA supplement | Oct 2, 2025 | FDA |
| Medtronic Vascular, Inc. | PMA supplement | Nov 7, 2025 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Feb 9, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Feb 11, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Feb 20, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Mar 23, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Apr 23, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Nov 5, 2026 | FDA |
Explore the linked device profile
Other records with product code NIP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Supera Peripheral Stent SystemP120020/S037 | Abbott Vascular (Idef Technologies Inc) | PMA supplement | Nov 6, 2026 | FDA |
| Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA | |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA | |
| BOSTON SCIENTIFIC CORPORATION | PMA supplement | Aug 21, 2026 | FDA | |
Innova Self Expanding Stent SystemP140028/S087 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Aug 6, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Vascular, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 3033 Campus Dr., Plymouth, MN, 55441
Sources and methodology
- Original FDA record: P110023/S068
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






